Clinical Trials Sponsored by Merck Services U.K. Ltd, UK

Total 213 results

Nutricia UK Ltd

Recruiting

Evaluation of Four New Ready to Drink Oral Nutritional Supplements: Adult ONS Trial

Malnutrition

United Kingdom
Nutricia UK Ltd

Completed

Bolus Pouch Feed Study

Stroke | Cancer | Gastrointestinal Dysfunction | Neurological Disorder | Oral Complication

United Kingdom
Nutricia UK Ltd

Completed

2kcal Tube Feed Study

Cancer | Enteral Nutrition

United Kingdom
Nutricia UK Ltd

Completed

GMP Case Studies of Tolerance, Safety and Acceptability in PKU and TYR

PKU | Tyrosinemias

United Kingdom
Inflazome UK Ltd

Completed

Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With Inzomelid

Healthy

Australia
Nutricia UK Ltd

Completed

Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia

Phenylketonurias | Hyperphenylalaninaemia, Type I

United Kingdom
Nutricia UK Ltd

Completed

High vs Standard Energy Children's Drink Study

Growth Failure
Nutricia UK Ltd

Completed

Amino Acid Feed Children's Study

Milk Hypersensitivity
Nutricia UK Ltd

Completed

An Investigation of the Efficacy of Oral Nutritional Supplements in Participants at Risk of Malnutrition

Malnutrition

United Kingdom
Nutricia UK Ltd

Completed

Nutritional Supplement Compliance Study (NSCS)

Undernutrition

United Kingdom
Nutricia UK Ltd

Recruiting

Childrens Real Food Tolerance Study

Malnutrition, Child

United Kingdom
Nutricia UK Ltd

Suspended

IDDSI Nutritional Drink for Dysphagia Study

Malnutrition | Dysphagia

United Kingdom
Nutricia UK Ltd

Completed

Protein Top-up Acceptability Study for Patients With Increased Protein Needs

Stroke | Cancer | Respiratory Disease | Neurological Injury

United Kingdom
Nutricia UK Ltd

Completed

HMF Preterm Case Studies

Preterm Infants

United Kingdom
Inflazome UK Ltd

Completed

Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334

Healthy Volunteers | Cryopyrin Associated Periodic Syndrome

Australia
Nutricia UK Ltd

Completed

GMP Drink for PKU Study

Phenylketonuria

United Kingdom
Nutricia UK Ltd

Withdrawn

Compliance, Tolerance and Acceptability of a Tablet Protein Substitute for the Dietary Management of Phenylketonuria

Phenylketonurias
Nutricia UK Ltd

Completed

Hospital Discharge Oral Nutrition Support Trial

Malnutrition

United Kingdom
Nutricia UK Ltd

Recruiting

Hydrolysed Rice Formula Study

Cow's Milk Protein Allergy

United Kingdom
Nutricia UK Ltd

Not yet recruiting

PKU Low Calorie Drink Study

Phenylketonurias | Hyperphenylalaninaemia
Nutricia UK Ltd

Active, not recruiting

Synbiotics Cohort Study

Cows Milk Allergy

United Kingdom
Nutricia UK Ltd

Completed

Synbiotic Extensively Hydrolysed Feed Study

Cow Milk Allergy

United Kingdom
Inflazome UK Ltd

Withdrawn

PK Study in Patients With Parkinson's Disease With IZD174

Parkinson Disease
Nutricia UK Ltd

Completed

High Energy High Protein Tube Feed Study

Nutrition

United Kingdom
Nutricia UK Ltd

Completed

Ketogenic Diet Drink Study

Intractable Epilepsy

United Kingdom
Biotronik UK Ltd.

Unknown

BIOFLOW-III UK Satellite Registry Orsiro Stent System

Coronary Artery Diseases

United Kingdom
Generic Devices Consulting, Inc.
Biocompatibles UK Ltd

Terminated

Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer (PARAGON)

Unresectable Metastatic Colo-rectal Cancer

United States
Nutricia UK Ltd
National Health Service, United Kingdom

Completed

High Energy High Protein Peptide Feed Study

Malnutrition | Malabsorption

United Kingdom
Vaccitech (UK) Limited
Clinical Network Services (CNS) Pty Ltd

Terminated

Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults

Influenza

Australia
Calcivis Ltd
Medsource UK Ltd.

Completed

Safety and Performance Evaluation of the Calcivis System

Dental Caries

United Kingdom
Calcivis Ltd
Medsource UK Ltd.

Completed

Caries Lesion Activity in Orthodontic Patients - Calcivis System

Dental Caries

United Kingdom
Oxford Vacmedix UK Ltd.

Recruiting

First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine

Ovarian Cancer | Prostate Cancer | Non Small Cell Lung Cancer

United Kingdom
MeiraGTx UK II Ltd

Completed

A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia

Head and Neck Cancer | Radiation-Induced Parotid Gland Hypofunction | Xerostomia Due to Radiotherapy

United States, Canada
MeiraGTx UK II Ltd

Completed

Natural History Study of Patients With Leber Congenital Amaurosis Associated With Mutations in RPE65

Leber Congenital Amaurosis

United Kingdom, United States
MeiraGTx UK II Ltd

Completed

Natural History Study for Achromatopsia

Achromatopsia

United Kingdom
BSN Medical Ltd. UK

Terminated

A Study to Evaluate the Benefits of Using a Range of Wound Care Products From a Single Manufacturer

Wound - in Medical Care

United Kingdom
Eliem Therapeutics (UK) Ltd.

Completed

Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

Lumbosacral Radiculopathy

United States
Eliem Therapeutics (UK) Ltd.

Completed

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain | Diabetic Peripheral Neuropathy

United States
MeiraGTx UK II Ltd

Completed

Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA) (OPTIRPE65)

Leber Congenital Amaurosis

United Kingdom, United States
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK (ECOS UK)

Growth Disorders

United Kingdom
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients

Relapsing Multiple Sclerosis

United Kingdom
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device (READER)

Relapsing Multiple Sclerosis

United Kingdom
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

Assessment of Patient Use of a New Device: RebiSmart

Multiple Sclerosis
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration

Multiple Sclerosis
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice (RESECT)

Metastatic Colorectal Cancer

United Kingdom
Acacia Pharma Ltd
Paion UK Ltd.

Active, not recruiting

Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

Pediatric ALL

United States, Denmark
Medialis Ltd.
Metabolic Support UK

Completed

Retrospective and Prospective Disease Progression and Quality of Life in XLH

X-linked Hypophosphatemia (XLH)

United Kingdom
Paion UK Ltd.
Aptiv Solutions

Completed

Remimazolam Phase II Cardiac Anesthesia Study

General Anesthesia

Germany
Verisfield UK Ltd. Greek Branch

Completed

Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)

Healthy

India
Verisfield UK Ltd. Greek Branch

Completed

Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate

Healthy

Jordan

Clinical Trials Sponsored by Merck Services U.K. Ltd, UK

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations